Back to CRL
CITADEL ADVISORS LLC CRL Position History
Charles River Laboratories International, Inc. • Healthcare
Quarters held
17
Latest value
$117K
Q2 2026
Peak value
$270.7M
First seen
Q1 2026
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2026 | $209.1M |
| Q1 2026 | $4.9M |
| Q1 2026 | $1.7M |
| Q2 2026 | $270.7M |
| Q2 2026 | $17.5M |
| Q2 2026 | $3.2M |
| Q2 2026 | $12K |
| Q2 2026 | $196K |
| Q2 2026 | $715K |
| Q2 2026 | $117K |
| Q2 2026 | $270.7M |
| Q2 2026 | $17.5M |
| Q2 2026 | $3.2M |
| Q2 2026 | $12K |
| Q2 2026 | $196K |
| Q2 2026 | $715K |
| Q2 2026 | $117K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $117K | 116.1K | — | — |
| Q2 2026 | $715K | 707.8K | — | — |
| Q2 2026 | $196K | 194.3K | — | — |
| Q2 2026 | $12K | 12.2K | — | — |
| Q2 2026 | $3.2M | 14.3K | — | — |
| Q2 2026 | $17.5M | 77.1K | — | — |
| Q2 2026 | $270.7M | 1.19M | — | — |
| Q2 2026 | $117K | 116.1K | — | — |
| Q2 2026 | $715K | 707.8K | — | — |
| Q2 2026 | $196K | 194.3K | — | — |
| Q2 2026 | $12K | 12.2K | — | — |
| Q2 2026 | $3.2M | 14.3K | — | — |
| Q2 2026 | $17.5M | 77.1K | — | — |
| Q2 2026 | $270.7M | 1.19M | — | — |
| Q1 2026 | $1.7M | 9.6K | — | — |
| Q1 2026 | $4.9M | 28.3K | — | — |
| Q1 2026 | $209.1M | 1.21M | — | — |
Other funds holding CRL
$508.3M
$422.8M
$422.8M
$371.4M
$362.1M
$334.6M
$328.4M
$323.2M